HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Giuseppe Leone Selected Research

Leukemia

5/2015Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias.
8/2013Newly proposed therapy-related myelodysplastic syndrome prognostic score predicts significant differences in overall survival and leukemia-free survival in patients treated with azacitidine.
1/2011Similarities and differences between therapy-related and elderly acute myeloid leukemia.
1/2011Incidence of acute myeloid leukemia after breast cancer.
12/2010The Syk inhibitor fostamatinib disodium (R788) inhibits tumor growth in the Eμ- TCL1 transgenic mouse model of CLL by blocking antigen-dependent B-cell receptor signaling.
12/2010Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia.
3/2010Incidence and susceptibility to therapy-related myeloid neoplasms.
9/2008PU.1 and CEBPA expression in acute myeloid leukemia.
10/2007Therapy-related leukemia and myelodysplasia: susceptibility and incidence.
7/2007All-trans retinoic acid in association with low dose cytosine arabinoside in the treatment of acute myeoid leukemia in elderly patients.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Giuseppe Leone Research Topics

Disease

40Neoplasms (Cancer)
01/2022 - 01/2002
27Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 01/2002
20Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2022 - 01/2002
15B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2013 - 11/2002
14Hodgkin Disease (Hodgkin's Disease)
03/2016 - 01/2002
14Leukemia
05/2015 - 09/2002
8Non-Hodgkin Lymphoma (Lymphosarcoma)
02/2014 - 01/2002
8Hematologic Neoplasms (Hematological Malignancy)
08/2012 - 02/2003
7Myocardial Infarction
04/2020 - 09/2004
7Lymphoma (Lymphomas)
01/2016 - 12/2003
7Venous Thromboembolism
01/2015 - 10/2002
7Thrombophilia
10/2011 - 01/2003
6Infections
01/2018 - 01/2007
6Thrombosis (Thrombus)
10/2017 - 10/2011
6Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
02/2013 - 02/2004
6Chromosome Aberrations (Chromosome Abnormalities)
01/2011 - 01/2002
5Intracranial Aneurysm (Cerebral Aneurysm)
06/2017 - 09/2014
5Autoimmune Diseases (Autoimmune Disease)
01/2017 - 12/2005
5Thrombocytosis (Thrombocythemia)
12/2014 - 10/2002
5Anemia
02/2014 - 01/2007
4Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2016 - 02/2006
4Graft vs Host Disease (Graft-Versus-Host Disease)
06/2013 - 12/2005
4Disease Progression
12/2011 - 06/2005
4Multiple Myeloma
06/2008 - 01/2002
3Ventricular Remodeling
04/2020 - 08/2007
3Ischemic Stroke
03/2019 - 01/2017
3Stroke (Strokes)
03/2019 - 02/2016
3Aneurysm (Aneurysms)
01/2018 - 08/2015
3Neutropenia
01/2018 - 04/2009
3Infarction (Infarctions)
02/2016 - 06/2005
3Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2015 - 02/2007
3Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
07/2014 - 09/2006
3Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
09/2013 - 03/2013
3Venous Thrombosis (Deep-Vein Thrombosis)
03/2013 - 06/2008
3Lymphoproliferative Disorders (Lymphoproliferative Disorder)
12/2011 - 02/2003
3Genetic Predisposition to Disease (Genetic Predisposition)
11/2011 - 08/2003
3Acute Coronary Syndrome
11/2008 - 09/2004
3Polycythemia Vera
10/2008 - 10/2002
2Ischemia
02/2018 - 01/2012
2Hematologic Diseases (Blood Diseases)
01/2015 - 10/2003
2Wounds and Injuries (Trauma)
01/2015 - 01/2003
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2014 - 11/2006
2Inflammation (Inflammations)
06/2013 - 05/2010
2Sepsis (Septicemia)
02/2013 - 04/2009
2POEMS Syndrome (Syndrome, POEMS)
06/2012 - 08/2008

Drug/Important Bio-Agent (IBA)

11Granulocyte Colony-Stimulating Factor (G-CSF)IBA
04/2020 - 05/2004
10Azacitidine (5 Azacytidine)FDA Link
01/2019 - 10/2003
8Rituximab (Mabthera)FDA Link
06/2015 - 09/2002
7Biological ProductsIBA
08/2012 - 01/2003
6DNA (Deoxyribonucleic Acid)IBA
01/2016 - 05/2003
6CytokinesIBA
01/2013 - 08/2006
6fludarabineIBA
12/2012 - 11/2002
5Alkylating AgentsIBA
01/2011 - 10/2007
5factor V LeidenIBA
06/2008 - 10/2002
5Glutathione Transferase (Glutathione S-Transferase)IBA
03/2007 - 10/2002
4Doxorubicin (Adriamycin)FDA LinkGeneric
03/2016 - 08/2002
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2015 - 02/2007
4Interleukin-6 (Interleukin 6)IBA
02/2014 - 05/2010
4EnzymesIBA
05/2010 - 06/2004
4CarcinogensIBA
03/2010 - 08/2003
4Prothrombin (Factor II)IBA
06/2008 - 10/2002
4Protein CIBA
06/2008 - 10/2002
4Pharmaceutical PreparationsIBA
07/2005 - 03/2002
3DecitabineFDA Link
04/2014 - 10/2003
3HepcidinsIBA
02/2014 - 05/2010
3Proteins (Proteins, Gene)FDA Link
06/2013 - 08/2008
3Alemtuzumab (Campath)FDA Link
12/2012 - 10/2004
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2012 - 01/2003
3Adrenal Cortex Hormones (Corticosteroids)IBA
04/2011 - 01/2007
3AntigensIBA
12/2010 - 06/2005
3AntithrombinsIBA
06/2008 - 10/2002
3Protein SIBA
06/2008 - 10/2002
3AnticoagulantsIBA
03/2008 - 10/2004
3Oral ContraceptivesIBA
11/2006 - 01/2003
3Gemtuzumab (Mylotarg)FDA Link
01/2006 - 05/2004
2Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2019 - 07/2007
2Dacarbazine (DIC)FDA LinkGeneric
03/2016 - 11/2011
2Vinblastine (Vinblastine Sulfate)FDA Link
03/2016 - 11/2011
2Bleomycin (Blenoxane)FDA LinkGeneric
03/2016 - 11/2011
2SilkFDA Link
02/2016 - 08/2015
2Biomarkers (Surrogate Marker)IBA
01/2016 - 07/2014
2Vincristine (Oncovin)FDA LinkGeneric
06/2015 - 11/2011
2Prednisone (Sone)FDA LinkGeneric
06/2015 - 11/2011
2Inosine Triphosphate (ITP)IBA
01/2015 - 02/2007
2Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
12/2014 - 02/2004
2IronIBA
01/2013 - 05/2010
2Hemoglobins (Hemoglobin)IBA
01/2013 - 05/2010
2Caspofungin (Cancidas)FDA Link
10/2012 - 11/2002
2Dexamethasone (Maxidex)FDA LinkGeneric
06/2012 - 02/2007
2Lenalidomide (CC 5013)FDA Link
06/2012 - 11/2011

Therapy/Procedure

46Therapeutics
01/2022 - 05/2003
25Drug Therapy (Chemotherapy)
11/2020 - 03/2002
14Stem Cell Transplantation
01/2019 - 03/2002
11Radiotherapy
01/2018 - 01/2002
6Stents
03/2019 - 09/2014
6Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
06/2012 - 02/2003
6Transplantation
04/2008 - 01/2002
5Thrombectomy
03/2019 - 10/2016
3Hematopoietic Stem Cell Transplantation
01/2018 - 06/2013
2Duration of Therapy
04/2013 - 02/2007